首页> 美国卫生研究院文献>Immunology >Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou China
【2h】

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou China

机译:广州市冠状病毒病2019年免疫病理特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Coronavirus disease 2019 (COVID‐19) is a respiratory disorder caused by the highly contagious severe acute respiratory syndrome coronavirus 2. The immunopathological characteristics of patients with COVID‐19, either systemic or local, have not been thoroughly studied. In the present study, we analysed both the changes in the number of various immune cell types as well as cytokines important for immune reactions and inflammation. Our data indicate that patients with severe COVID‐19 exhibited an overall decline of lymphocytes including CD4 and CD8 T cells, B cells and natural killer cells. The number of immunosuppressive regulatory T cells was moderately increased in patients with mild COVID‐19. Interleukin‐6 (IL‐6), IL‐10 and C‐reactive protein were remarkably up‐regulated in patients with severe COVID‐19. In conclusion, our study shows that the comprehensive decrease of lymphocytes, and the elevation of IL‐6, IL‐10 and C‐reactive protein are reliable indicators of severe COVID‐19.
机译:冠状病毒病2019(COVID-19)是由高度传染性严重急性呼吸系统综合症冠状病毒2引起的呼吸系统疾病。尚未对COVID-19的全身或局部患者的免疫病理学特征进行彻底研究。在本研究中,我们分析了各种免疫细胞类型以及对于免疫反应和炎症重要的细胞因子的数量变化。我们的数据表明患有严重COVID-19的患者的淋巴细胞总体下降,包括CD4和CD8 T细胞,B细胞和自然杀伤细胞。轻度COVID-19患者的免疫抑制调节性T细胞数量适度增加。严重COVID-19的患者白细胞介素6(IL-6),IL-10和C反应蛋白显着上调。总之,我们的研究表明,淋巴细胞的全面减少以及IL-6,IL-10和C反应蛋白的升高是严重COVID-19的可靠指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号